Evidence map›Paper›PMID 35740219›Full record

ArticleAntibiotics (Basel, Switzerland)2022

Predicting In-Hospital Antibiotic Use in the Medical Department: Derivation and Validation Study.

Itamar Poran, Michal Elbaz, Adi Turjeman, Maayan Huberman Samuel, Noa Eliakim-Raz, Jeries Nashashibi, Mical Paul, Leonard Leibovici

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Itamar PoranDepartment of Medicine E, Rabin Medical Center, Beilinson Hospital, Petach Tikva 4941492, Israel.ORCID 0000-0003-4751-7413
Michal ElbazDepartment of Medicine E, Rabin Medical Center, Beilinson Hospital, Petach Tikva 4941492, Israel.
Adi TurjemanDepartment of Medicine E, Rabin Medical Center, Beilinson Hospital, Petach Tikva 4941492, Israel.
Maayan Huberman SamuelDepartment of Medicine E, Rabin Medical Center, Beilinson Hospital, Petach Tikva 4941492, Israel.
Noa Eliakim-RazDepartment of Medicine E, Rabin Medical Center, Beilinson Hospital, Petach Tikva 4941492, Israel.
Jeries NashashibiDepartment of Medicine D, Rambam Health Care Campus, Haifa 3436212, Israel.ORCID 0000-0002-5681-018X
Mical PaulInfectious Diseases Institute, Rambam Health Care Campus, Haifa 3436212, Israel.
Leonard LeiboviciDepartment of Medicine E, Rabin Medical Center, Beilinson Hospital, Petach Tikva 4941492, Israel.
Tel Aviv University · ILRabin Medical Center · ILRambam Health Care Campus · ILTechnion – Israel Institute of Technology · IL

Funding

Chief Scientist Office of the Ministry of Health, Israel 3-0000-14861
6 · The paper itself

Abstract

backgroundThe rise of multi-drug-resistant pathogens and nosocomial infections among hospitalized patients is partially attributed to the increased use of antibiotic therapy. A prediction model for in-hospital antibiotic treatment could be valuable to target preventive strategies.

methodsThis was a retrospective cohort study, including patients admitted in 2018 to medical departments and not treated with antibiotics during the first 48 h. Data available at hospital admission were used to develop a logistic model to predict the probability of antibiotic treatment during hospitalization. The performance of the model was evaluated in two independent validation cohorts.

resultsIn the derivation cohort, antibiotic treatment was initiated in 454 (8.1%) out of 5592 included patients. Male gender, lower functional capacity, prophylactic antibiotic treatment, medical history of atrial fibrillation, peripheral vascular disease, solid organ transplantation, chronic use of a central venous catheter, urinary catheter and nasogastric tube, albumin level, mental status and vital signs at presentation were identified as predictors for antibiotic use during hospitalization and were included in the prediction model. The area under the ROC curve (AUROC) was 0.72 (95% CI 0.70-0.75). In the highest probability group, the percentage of antibiotic treatment was 18.2% (238/1,307). In the validation cohorts, the AUROC was 0.73 (95% CI 0.68-0.77) and 0.75 (95% CI 0.72-0.78). In the highest probability group, the percentage of antibiotic treatment was 12.5% (66/526) and 20.7% (244/1179) of patients.

conclusionsOur prediction model performed well in the validation cohorts and was able to identify a subgroup of patients at high risk for antibiotic treatment.

Indexed as

antibiotic prescriptionantibiotic stewardshipepidemiologyprediction model

Identifiers

PMID35740219
PMCPMC9219723
OpenAlexW4283033974

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.